ANGO News and Press, AngioDynamics Inc. From 10/03/19

ANGO stock is down 16% today after MedDev company AngioDynamics Inc (NSADAQ:ANGO) agreed to acquire Eximo Medical for $46 million USD. The New York medical devices company has announced that it will acquire Israeli startup Eximo Medical Ltd, which develops a laser technology catheter de...

Gainers: PDS Biotechnology (NASDAQ: PDSB ) +23% . The Meet Group (NASDAQ: MEET ) +20% . Synthesis Energy Systems (NASDAQ: SES ) +14% . Microbot Medical (NASDAQ: MBOT ) +19% . TuanChe (NASDAQ: TC ) +14% . Arcturus Therapeutics Holdings (NASDAQ: ARCT ) +14% . Sorrento Therapeutics (NA...

AngioDynamics, Inc. (ANGO) Q1 2020 Results Conference Call October 03, 2019 08:00 AM ET Company Participants Jim Clemmer - President and CEO Michael Greiner - EVP and CFO Steve Trowbridge - SVP and General Counsel Conference Call Participants Matthew Mishan - KeyBanc Jaso...

AngioDynamics ( ANGO -16.7% ) acquired Eximo Medical, an early commercial stage, medical device company, for $46M in up-front with up to $20M of contingent consideration. More news on: AngioDynamics, Inc., Healthcare stocks news, Merger & acquisition news, Read more ...

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2020 Q1 earnings Read more ...

AngioDynamics ( ANGO ) Q1 results : Revenues: $66M (+3.3%). More news on: AngioDynamics, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...

AngioDynamics (NASDAQ: ANGO ): Q1 Non-GAAP EPS of $0.08 beats by $0.04 ; GAAP EPS of -$0.03 beats by $0.09 . More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Fiscal 2020 First Quarter Highlights Net sales of $66.0 million, an increase of 3.3% year over year Gross margin increased 170 basis points year over year to 57.9% GAAP loss per share of $0.03; adjusted earnings per share of $0.08 AngioDynamics, Inc. (NASDAQ: AN...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has acquired Eximo Medical, Ltd., an early commercial stage, medical device company, and its proprie...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that the Company has been awarded a dual-source group purchasing agreement by Premier, Inc. to supply implan...